Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP ALMEIDA, Kelson James FMUSP-HC
MACEDO, Livio Pereira de
LOPES, Janine Lemos de Melo Lobo Jofili
CAMPOS-SOUSA, Raimundo Nonato
BARBOSA, Egberto Reis FMUSP-HC 2017
dc.identifier.citation JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, v.30, n.5, p.261-266, 2017
dc.identifier.issn 0891-9887
dc.description.abstract Introduction: It was proposed to modify the Pfeffer questionnaire (PQ) for functional assessment in patients with Parkinson disease (PD). Aim: To determine the cutoff score for diagnosis of functional impairment in patients with PD by modified PQ (mPQ). Methods: A total of 110 patients with PD were enrolled into the study, and a neuropsychological test battery was performed to assess their cognitive status. Regarding functional assessment, the mPQ has been applied, and their results were compared to the functional assessment by Informant Questionnaire on Cognitive Decline in the Elderly adapted for use in Brazil (IQCODE-BR). The statistical analysis was accomplished through receiver operating characteristic (ROC) curve with evaluation of the area under the curve, sensitivity, and specificity of the new cutoff point. Results: Eighty-nine patients with PD were evaluated with a mean age of 63.69 +/- 9.14 years. Cognitive status categorization was 28.10% as normal, 44.94% as mild cognitive impairment, and 26.96% of patients as dementia associated with PD. The average score on PQ was 3.49 +/- 4.79 and on the mPQ 2.56 +/- 3.49. In IQCODE-BR, the average score was 6.75 +/- 32.72. The ROC curve for the new cutoff point presented 47.4% sensitivity, 88.10% specificity, and 0.757 of area under the curve, with a standard deviation of 0.055 (95% confidence interval: 0.650-0.864). Conclusion: 3.5 is proposed as the cutoff point to define functional impairment in patients with PD by mPQ.
dc.language.iso eng
dc.relation.ispartof Journal of Geriatric Psychiatry and Neurology
dc.rights restrictedAccess
dc.subject Parkinson disease; questionnaires; cognition
dc.subject.other mild cognitive impairment; society task-force; informant-questionnaire; diagnostic-criteria; elderly iqcode; dementia; decline; depression; prognosis; cohort
dc.title Modified Pfeffer Questionnaire for Functional Assessment in Parkinson Disease
dc.type article
dc.rights.holder Copyright SAGE PUBLICATIONS INC LIM/26 LIM/45
dc.identifier.doi 10.1177/0891988717720298
dc.identifier.pmid 28747137
dc.type.category original article
dc.type.version publishedVersion ALMEIDA, Kelson James:FM: BOR-SENG-SHU, Edson:HC:ICHC BARBOSA, Egberto Reis:HC:ICHC · MACEDO, Livio Pereira de:Facid Devry Univ Med, Dept Neurol, Canada St 2070, Teresina, Piaui, Brazil
· LOPES, Janine Lemos de Melo Lobo Jofili:Univ Fed Piaui, Dept Neurol, Teresina, Piaui, Brazil
· CAMPOS-SOUSA, Raimundo Nonato:Univ Fed Piaui, Dept Neurol, Teresina, Piaui, Brazil 2-s2.0-85029640661 WOS:000417081500003 THOUSAND OAKS USA
hcfmusp.relation.reference · Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387
· Tedrus GMAS, 2009, ARQ NEURO-PSIQUIAT, V67, P423, DOI 10.1590/S0004-282X2009000300010
· Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y
· Comella CL, 2006, J NEURAL TRANSM-SUPP, P349
· COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095
· Cummings JL, 1999, INT J GERIATR PSYCH, V14, P711, DOI 10.1002/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1
· de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265
· dos Santos AA, 2011, ACTA PAUL ENFERM, V24, P520, DOI 10.1590/S0103-21002011000400012
· Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844
· Dutra Marina Carneiro, 2015, Dement. neuropsychol., V9, P176, DOI 10.1590/1980-57642015DN92000012
· Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507
· Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067
· Freitas S., 2010, AVAL PSICOL, V9, P345
· Hobson P, 2004, MOVEMENT DISORD, V19, P1043, DOI 10.1002/mds.20216
· Huang XM, 2006, ARCH NEUROL-CHICAGO, V63, P189, DOI 10.1001/archneur.63.2.189
· JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209
· Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390
· Kempster PA, 2007, NEUROLOGY, V69, P482, DOI 10.1212/01.wnl.0000266639.50620.d1
· Lemke MR, 2004, J NEUROL, V251, P24, DOI 10.1007/s00415-004-1606-6
· Levy G, 2002, MOVEMENT DISORD, V17, P1221, DOI 10.1002/mds.10280
· Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893
· Lucetti C, 2006, PARKINSONISM RELAT D, V12, P279, DOI 10.1016/j.parkreldis.2005.12.005
· Melo LM, 2007, REV PSIQUIATRIA CLIN, V34, P176
· Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110
· PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323
· Sanchez Maria Angélica dos Santos, 2011, Dement. neuropsychol., V5, P322, DOI 10.1590/S1980-57642011DN05040010
· Sanchez MAD, 2009, CAD SAUDE PUBLICA, V25, P1455, DOI 10.1590/S0102-311X2009000700003
· Thanvi BR, 2004, POSTGRAD MED J, V80, P452, DOI 10.1136/pgmj.2003.013912
· Todorova Antoniya, 2014, Pract Neurol, V14, P310, DOI 10.1136/practneurol-2013-000741
· Watson GS, 2010, BRAIN PATHOL, V20, P640, DOI 10.1111/j.1750-3639.2010.00373.x
· Wullner U, 2007, EUR J NEUROL, V14, P1405, DOI 10.1111/j.1468-1331.2007.01982.x
· Xia RP, 2012, NEUROSCI BULL, V28, P39, DOI 10.1007/s12264-012-1050-z
dc.description.index MEDLINE
dc.identifier.eissn 1552-5708
hcfmusp.citation.scopus 1
hcfmusp.citation.wos 0 Brasil

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account